✦ LIBER ✦

Repeat prostate biopsy in the Prostate, Lung, Colorectal and Ovarian cancer screening trial

✍ Scribed by Paul F. Pinsky; E. David Crawford; Barnett S. Kramer; Gerald L. Andriole; Edward P. Gelmann; Robert Grubb; Robert Greenlee; John K. Gohagan

Book ID: 109053093
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 103 KB
Volume: 99
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.2007.06708.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Diabetes mellitus and prostate cancer ri

Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

✍ Michael F. Leitzmann; Jiyoung Ahn; Demetrius Albanes; Ann W. Hsing; Arthur Schat 📂 Article 📅 2008 🏛 Springer Netherlands 🌐 English ⚖ 246 KB

Adherence to repeat screening flexible s

Adherence to repeat screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial

✍ Joel L. Weissfeld; Bruce S. Ling; Robert E. Schoen; Robert S. Bresalier; Thomas 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

## Abstract ## BACKGROUND Acceptance of screening flexible sigmoidoscopy has been poor, in part because of providers' concerns regarding the acceptability of the procedure. In the current prospective study, the authors used adherence to repeat testing to assess the acceptability of screening flexi

The prostate, lung, colorectal, and ovar

The prostate, lung, colorectal, and ovarian cancer screening trial of the national cancer institute

✍ John K. Gohagan; Philip C. Prorok; Barnett S. Kramer; Richard B. Hayes; Joyce E. 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 481 KB 👁 2 views

The two-year pilot phase of the Prostate, Lung, Colorectal, and Ovarian (PLCO) trial concluded September 29, 1994. The goals, organization, operation, and recruitment status of the trial are discussed. The PLCO trial is a 16year randomized controlled screening trial involving 148,000 male and female

A national cancer institute sponsored sc

A national cancer institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers

✍ Barnett S. Kramer; John Gohagan; Philip C. Prorok; Charles Smart 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 522 KB

Background. Ovarian cancer is the fifth most common cause of cancer-related death in American women. The median age at diagnosis is about 62 years; incidence rises rapidly after age 60. Pelvic examination has been the primary method for detection of ovarian carcinoma. It is insensitive for the detec

Image Quality Assurance in the Prostate,

Image Quality Assurance in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Network of the National Lung Screening Trial

✍ Stephen M. Moore; David S. Gierada; Kenneth W. Clark; G. James Blaine 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 768 KB

Prostate cancer screening in the Prostat

Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial

✍ Robert L. Grubb III; Paul F. Pinsky; Robert T. Greenlee; Grant Izmirlian; Anthon 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB